Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.
about
Aclidinium bromide for stable chronic obstructive pulmonary diseaseEfficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease.Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.Muscarinic Receptor Antagonists.
P2860
Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@ast
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@en
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@nl
type
label
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@ast
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@en
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@nl
prefLabel
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@ast
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@en
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@nl
P2860
P1433
P1476
Aclidinium bromide twice daily ...... e pulmonary disease: a review.
@en
P2093
Paul Jones
P2860
P2888
P304
P356
10.1007/S12325-013-0019-2
P407
P577
2013-04-02T00:00:00Z
P6179
1013720133